Stockreport

What's Next for Esperion Therapeutics' Cholesterol-Lowering Drug [The Motley Fool]

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
PDF The company's making big strides toward winning approval of its first commercial medicine. Esperion Therapeutics ( NASDAQ:ESPR )  reported positive results f [Read more]